Fagron SA (4A5) Price & Analysis

4A5 Stock Chart & Stats

€23.25-€0.50(-2.11%)

At close: Oct 30 4:00 PM EDT

Day’s Range: EUR 23.25 - EUR 23.25
52-Week Range: EUR 19.94 - EUR 25.15
Previous Close: EUR 23.75
Volume: 0
Average Volume (3M): 5
Market Cap: EUR 1.73B
Enterprise Value: EUR 2.28B
Total Cash (Recent Filing): EUR 115.92M
Total Debt (Recent Filing): EUR 386.73M
Price to Earnings (P/E): 18.8
Beta: 0.32
Next Earnings: Feb 11, 2027
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: 1.68%

Fagron SA News

Aberdeen Group Lifts Stake in Fagron Above 3% Disclosure Threshold

Fagron SA ( ($GB:0HNZ) ) has issued an announcement. Fagron has disclosed a transparency notification indicating that Aberdeen Group plc has increased its stake in the company above the 3%

1w agoARSUF 4A5

BlackRock Trims Stake in Fagron Below 3% Transparency Threshold

The latest announcement is out from Fagron SA ( ($GB:0HNZ) ). Fagron, a specialist in pharmaceutical compounding, delivers personalized medicines to hospitals, pharmacies, clinics and patients across more than 38

2w agoARSUF 4A5

Fagron posts double-digit Q3 growth and reaffirms 2026 outlook

Fagron SA ( ($GB:0HNZ) ) just unveiled an announcement. Fagron reported third-quarter revenue of €281.3 million, a 23.2% increase driven by strong performances in EMEA, Latin America and the Brands

3w agoARSUF 4A5

BlackRock Crosses 3% Ownership Threshold in Fagron

An update from Fagron SA ( ($GB:0HNZ) ) is now available. Fagron disclosed that BlackRock, Inc. has crossed the 3% transparency threshold in its share capital under Belgian law on

1M agoARSUF 4A5

Fagron Fine-Tunes Capital Structure With Targeted Share Issue

Fagron SA ( ($GB:0HNZ) ) just unveiled an update. Fagron, a leading international player in pharmaceutical compounding, provides personalized medicines to hospitals, pharmacies, clinics and patients across more than 38

1M agoARSUF 4A5

Fagron posts double-digit H1 growth and affirms 2026 outlook

Fagron SA ( ($GB:0HNZ) ) has shared an update. Fagron reported a strong first half of 2026, with revenue rising 16.0% to €552.5 million and adjusted EBITDA up 12.7% to

3M agoARSUF 4A5

Fagron price target raised to EUR 29 from EUR 28 at Berenberg

Berenberg raised the firm’s price target on Fagron (ARSUF) to EUR 29 from EUR 28 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate

7M agoARSUF 4A5

Fagron Releases 2024 Annual Report Ahead of Shareholders’ Meeting

The latest update is out from Fagron SA ( ($GB:0HNZ) ). Fagron has released its annual report for 2024, with discussions and approval of the annual accounts scheduled for the

1y ago4A5 0HNZ

Fagron Reports Robust 2024 Growth and Strategic Acquisitions

Fagron SA ( ($GB:0HNZ) ) just unveiled an update. Fagron reported a strong financial performance for 2024, achieving a 14.3% increase in revenue and a 16.8% rise in REBITDA, driven

1y ago4A5 0HNZ

Fagron Expands Iberian Market Presence with Guinama Acquisition

The latest update is out from Fagron SA ( ($GB:0HNZ) ). Fagron, a global leader in pharmaceutical compounding, has announced the acquisition of Guinama, a Spanish company known for repackaging

1y ago4A5 0HNZ

Fagron Expands Market Reach with Key Acquisitions in North America and Brazil

Fagron SA ( ($GB:0HNZ) ) has provided an update. Fagron has announced strategic acquisitions of CareFirst Specialty Pharmacy in North America and Injeplast in Brazil, with a combined value of

1y ago4A5 0HNZ

4A5 FAQ

What was Fagron SA’s price range in the past 12 months?

Fagron SA lowest stock price was €19.94 and its highest was €25.15 in the past 12 months.

What is Fagron SA’s market cap?

Fagron SA’s market cap is €1.73B.

When is Fagron SA’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Fagron SA’s earnings last quarter?

Fagron SA released its earnings results on Jul 30, 2026. The company reported €0.631 earnings per share for the quarter.

Is Fagron SA overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Fagron SA pay dividends?

Fagron SA does not currently pay dividends.

What is Fagron SA’s EPS estimate?

Fagron SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Fagron SA have?

Fagron SA has 73,817,024 shares outstanding.

What happened to Fagron SA’s price movement after its last earnings report?

Fagron SA reported an EPS of €0.631 in its last earnings report. Following the earnings report the stock price went up 0.866%.

Which hedge fund is a major shareholder of Fagron SA?

Currently, no hedge funds are holding shares in DE:4A5

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Fagron SA

Fagron N.V. operates as a pharmaceutical compounding enterprise, dedicated to providing customized medicinal solutions for hospitals, pharmacies, clinics, and individual patients. The company is actively involved in developing innovative concepts, delivery systems, and formulations within the compounding sector. Its extensive offerings encompass essential raw materials, specialized equipment, semi-finished products, various drug vehicles, and both sterile and non-sterile custom-prepared medications. Additionally, through the Fagron Academy, the firm delivers educational and training programs to healthcare prescribers and pharmacists. With a significant global footprint, Fagron conducts operations across Latin America, North America, Europe, the Middle East, and Africa. Founded in 1990 and headquartered in Nazareth, Belgium, the company adopted its current name, Fagron NV, in January 2015, having previously been known as Arseus NV.

Fagron SA (4A5) Earnings & Revenues

Historic Earnings Reports

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	15	2	4
Technical Analysis	3	2	4
Moving Averages	12	0	0

Technical Analysis >

Similar Stocks

Stocks similar to DE:4A5
Company	Price & Change	Follow
GB:0HNZFagron SA
GB:PRTCPureTech Health
GB:GDRGenedrive

Compare DE:4A5 Stocks >

Ownership Overview

9.36% Mutual Funds
82.05% Public Companies and Individual Investors

Detailed Ownership Overview >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

Fagron SA stock analysis

Fagron SA (4A5) Price & Analysis

4A5 Stock Chart & Stats

Fagron SA News

Aberdeen Group Lifts Stake in Fagron Above 3% Disclosure Threshold

BlackRock Trims Stake in Fagron Below 3% Transparency Threshold

Fagron posts double-digit Q3 growth and reaffirms 2026 outlook

BlackRock Crosses 3% Ownership Threshold in Fagron

Fagron Fine-Tunes Capital Structure With Targeted Share Issue

Fagron posts double-digit H1 growth and affirms 2026 outlook

Fagron price target raised to EUR 29 from EUR 28 at Berenberg

Fagron Releases 2024 Annual Report Ahead of Shareholders’ Meeting

Fagron Reports Robust 2024 Growth and Strategic Acquisitions

Fagron Expands Iberian Market Presence with Guinama Acquisition

Fagron Expands Market Reach with Key Acquisitions in North America and Brazil

4A5 FAQ

Company Description

Fagron SA

Fagron SA (4A5) Earnings & Revenues

Technical Analysis

Overall Consensus

Similar Stocks

Ownership Overview

Popular Stocks

Become an Expert with TipRanks Premium